AMN107A
Showing 26 - 50 of 9,215
Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Houston (DSP107, Azacitidine, Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- DSP107
- +2 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center, Department of
Nov 13, 2022
Relapsed Malignant Solid Tumor Trial in India (AUR107)
Not yet recruiting
- Relapsed Malignant Solid Neoplasm
-
Vijayawada, Andhra Pradesh, India
- +6 more
May 9, 2023
Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)
Completed
- Chronic Myeloid Leukemia
- Acute Lymphoblastic Leukemia
-
Bordeaux, Aquitaine, France
- +11 more
Dec 6, 2020
Hypertension Trial in Cincinnati (CIN-107, Matching Placebo)
Completed
- Hypertension
- CIN-107
- Matching Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Aug 12, 2022
Pain, Postoperative Pain, Pain, Acute Trial in Salt Lake City (MR-107A-01, Placebo)
Chronic Myeloid Leukemia Trial in Germany (Nilotinib)
Completed
- Chronic Myeloid Leukemia
-
Mannheim, Baden-Wuerttemberg, Germany
- +69 more
Mar 21, 2022
Acute Pain, Post Operative Pain, Pain Trial in Salt Lake City (MR-107A-02, Placebo)
Completed
- Acute Pain
- +2 more
- MR-107A-02
- Placebo
-
Salt Lake City, UtahResearch Facility 201
Jul 1, 2022
Diabetic Macular Edema (DME) Trial in United States (AXT107 0.1 mg, AXT107 0.25 mg, AXT107 0.5 mg)
Active, not recruiting
- Diabetic Macular Edema (DME)
- AXT107 0.1 mg
- +2 more
-
Gilbert, Arizona
- +9 more
Jul 19, 2022
Chronic Myelogenous Leukemia Trial in Turkey (Nilotinib)
Completed
- Chronic Myelogenous Leukemia
-
Eskisehir, Meselik, Turkey
- +12 more
Aug 18, 2020
Neovascular Age-Related Macular Degeneration (nAMD) Trial in United States (AXT107 0.1 mg, AXT107 0.25 mg, AXT107 0.5 mg)
Active, not recruiting
- Neovascular Age-Related Macular Degeneration (nAMD)
- AXT107 0.1 mg
- +2 more
-
Gilbert, Arizona
- +9 more
Jul 19, 2022
Freezing of Gait Symptoms in Parkinson's Disease Trial in Sydney (CST-103, CST-107, matching )
Not yet recruiting
- Freezing of Gait Symptoms in Parkinson's Disease
- CST-103, CST-107, matching placebo
-
Sydney, New South Wales, AustraliaThe University of Sydney
Jun 1, 2022
Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)
Completed
- Chronic Myelogenous Leukemia
-
Fayetteville, Arkansas
- +22 more
Jun 29, 2021
Mild Cognitive Impairment, Dementia Trial in United States (CST-2032, matching for CST-2032, CST-107, matching for CST-107)
Recruiting
- Mild Cognitive Impairment
- Dementia
- CST-2032, matching placebo for CST-2032, CST-107, matching placebo for CST-107
-
Scottsdale, Arizona
- +14 more
Jan 4, 2023
Advanced Solid Tumor, Non Small Cell Lung Cancer Trial in United States (DSP107, Atezolizumab)
Recruiting
- Advanced Solid Tumor
- Non Small Cell Lung Cancer
- DSP107
- Atezolizumab
-
La Jolla, California
- +4 more
Mar 28, 2022
Newly Diagnosed Glioblastoma Trial in China, Hong Kong (TJ107, TJ107 )
Recruiting
- Newly Diagnosed Glioblastoma
- TJ107
- TJ107 placebo
-
Shenzhen, Guangdong, China
- +15 more
Jul 6, 2022
MRSA Bloodstream Infection, MRSA Bacteremia, MRSA Right-sided Endocarditis Trial in Butte, Toledo (Exebacase)
No longer available
- MRSA Bloodstream Infection
- +3 more
-
Butte, Montana
- +1 more
Aug 25, 2022